Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006400HBVENSG00000006071.16protein_codingABCC8NoNo6833Q09428
TVIS10014476HBVENSG00000006071.16protein_codingABCC8NoNo6833Q09428
TVIS20010586HPVENSG00000006071.16protein_codingABCC8NoNo6833Q09428
TVIS44004571HTLV-1ENSG00000006071.16protein_codingABCC8NoNo6833Q09428
TVIS44020396HTLV-1ENSG00000006071.16protein_codingABCC8NoNo6833Q09428
TCGA Plot Options
Drug Information
GeneABCC8
DrugBank IDDB01067
Drug NameGlipizide
Target IDBE0000207
UniProt IDQ09428
Regulation Typeinhibitor
PubMed IDs11078468; 11078469; 11484080; 11574406; 12475777
CitationsGribble FM, Ashcroft FM: Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism. 2000 Oct;49(10 Suppl 2):3-6.@@Harrower A: Gliclazide modified release: from once-daily administration to 24-hour blood glucose control. Metabolism. 2000 Oct;49(10 Suppl 2):7-11.@@Lawrence CL, Proks P, Rodrigo GC, Jones P, Hayabuchi Y, Standen NB, Ashcroft FM: Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Diabetologia. 2001 Aug;44(8):1019-25.@@Reimann F, Ashcroft FM, Gribble FM: Structural basis for the interference between nicorandil and sulfonylurea action. Diabetes. 2001 Oct;50(10):2253-9.@@Proks P, Reimann F, Green N, Gribble F, Ashcroft F: Sulfonylurea stimulation of insulin secretion. Diabetes. 2002 Dec;51 Suppl 3:S368-76.
GroupsApproved; Investigational
Direct ClassificationBenzenesulfonamides
SMILESCC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1
Pathways
PharmGKBPA449762
ChEMBLCHEMBL1073